Overview

Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Status:
Completed
Trial end date:
2016-04-15
Target enrollment:
Participant gender:
Summary
This phase II trial is evaluating the efficacy of concurrent chemoradiation therapy with weekly docetaxel and cisplatin combination regimen.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Cisplatin
Docetaxel